162 related articles for article (PubMed ID: 30840925)
1. Hederagenin amide derivatives as potential antiproliferative agents.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Ataide Martins JP; Fischer Nee Heller L; Csuk R
Eur J Med Chem; 2019 Apr; 168():436-446. PubMed ID: 30840925
[TBL] [Abstract][Full Text] [Related]
2. Hederagenin as a triterpene template for the development of new antitumor compounds.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
[TBL] [Abstract][Full Text] [Related]
3. Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Heller L; Csuk R
Eur J Med Chem; 2016 Jun; 115():257-67. PubMed ID: 27017553
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y
Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and proapoptotic activity of oleanolic acid derived amides.
Heller L; Knorrscheidt A; Flemming F; Wiemann J; Sommerwerk S; Pavel IZ; Al-Harrasi A; Csuk R
Bioorg Chem; 2016 Oct; 68():137-51. PubMed ID: 27518757
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
9. Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Nain-Perez A; Ferreira SR; Fujiwara RT; de Almeida RM; Heller L; Csuk R
Eur J Med Chem; 2017 Nov; 140():624-635. PubMed ID: 29024910
[TBL] [Abstract][Full Text] [Related]
10. Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.
Wolfram RK; Heller L; Csuk R
Eur J Med Chem; 2018 May; 152():21-30. PubMed ID: 29684707
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of ring-C modified oleanolic acid derivatives and their cytotoxic evaluation.
Pattnaik B; Lakshma Nayak V; Ramakrishna S; Venkata Mallavadhani U
Bioorg Chem; 2016 Oct; 68():152-8. PubMed ID: 27522460
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel steroidal pyrazole amides as highly potent anticancer agents.
Huo H; Jiang W; Sun F; Li J; Shi B
Steroids; 2021 Dec; 176():108931. PubMed ID: 34655595
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
14. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.
Wolfram RK; Fischer L; Kluge R; Ströhl D; Al-Harrasi A; Csuk R
Eur J Med Chem; 2018 Jul; 155():869-879. PubMed ID: 29960206
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
16. Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation.
Ashraf Z; Mahmood T; Hassan M; Afzal S; Rafique H; Afzal K; Latip J
Drug Des Devel Ther; 2019; 13():1643-1657. PubMed ID: 31190743
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Wang X; Ren QW; Liu XX; Yang YT; Wang BH; Zhai R; Qi JG; Tian JW; Wang HB; Bi Y
Eur J Med Chem; 2019 Jan; 161():364-377. PubMed ID: 30384042
[TBL] [Abstract][Full Text] [Related]
18. Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; de Almeida RM; Fujiwara RT; Ferreira SR
Eur J Med Chem; 2016 Nov; 124():153-159. PubMed ID: 27569196
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents.
Yang SJ; Liu MC; Zhao Q; Hu DY; Xue W; Yang S
Eur J Med Chem; 2015; 96():58-65. PubMed ID: 25874331
[TBL] [Abstract][Full Text] [Related]
20. 11-Keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells.
Csuk R; Barthel-Niesen A; Barthel A; Schäfer R; Al-Harrasi A
Eur J Med Chem; 2015 Jul; 100():98-105. PubMed ID: 26073487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
